BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Babji S, Kang G. Rotavirus vaccination in developing countries. Curr Opin Virol. 2012;2:443-448. [PMID: 22698800 DOI: 10.1016/j.coviro.2012.05.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Huang S, Fan B, Niu B, Guo R, Gu J, Gao S, Li B. iTRAQ-based proteome analysis of porcine group A rotavirus-infected porcine IPEC-J2 intestinal epithelial cells. J Proteomics 2021;248:104354. [PMID: 34418579 DOI: 10.1016/j.jprot.2021.104354] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Rogawski McQuade ET, Liu J, Kang G, Kosek MN, Lima AAM, Bessong PO, Samie A, Haque R, Mduma ER, Shrestha S, Leite JP, Bodhidatta L, Iqbal N, Page N, Kiwelu I, Bhutta Z, Ahmed T, Houpt ER, Platts-Mills JA. Protection From Natural Immunity Against Enteric Infections and Etiology-Specific Diarrhea in a Longitudinal Birth Cohort. J Infect Dis 2020;222:1858-68. [PMID: 31984416 DOI: 10.1093/infdis/jiaa031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
3 Hallowell BD, Tate J, Parashar U. An overview of rotavirus vaccination programs in developing countries. Expert Rev Vaccines 2020;19:529-37. [PMID: 32543239 DOI: 10.1080/14760584.2020.1775079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 De Jesus MCS, Santos VS, Storti-melo LM, De Souza CDF, Barreto ÍDDC, Paes MVC, Lima PAS, Bohland AK, Berezin EN, Machado RLD, Cuevas LE, Gurgel RQ. Impact of a twelve-year rotavirus vaccine program on acute diarrhea mortality and hospitalization in Brazil: 2006-2018. Expert Review of Vaccines 2020;19:585-93. [DOI: 10.1080/14760584.2020.1775081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Engevik MA, Banks LD, Engevik KA, Chang-Graham AL, Perry JL, Hutchinson DS, Ajami NJ, Petrosino JF, Hyser JM. Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence. Gut Microbes 2020;11:1324-47. [PMID: 32404017 DOI: 10.1080/19490976.2020.1754714] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
6 Civra A, Altomare A, Francese R, Donalisio M, Aldini G, Lembo D. Colostrum from cows immunized with a veterinary vaccine against bovine rotavirus displays enhanced in vitro anti-human rotavirus activity. J Dairy Sci 2019;102:4857-69. [PMID: 30981494 DOI: 10.3168/jds.2018-16016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
7 Carvalho MF, Gill D. Rotavirus vaccine efficacy: current status and areas for improvement. Hum Vaccin Immunother 2019;15:1237-50. [PMID: 30215578 DOI: 10.1080/21645515.2018.1520583] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
8 Parrón JA, Ripollés D, Ramos SJ, Pérez MD, Calvo M, Sánchez L. Effect of thermal and high-pressure treatments on the antirotaviral activity of human milk fractions. Innovative Food Science & Emerging Technologies 2018;47:262-70. [DOI: 10.1016/j.ifset.2018.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Parrón JA, Ripollés D, Sánchez AC, Pérez MD, Calvo M, López S, Arias CF, Sánchez L. Antirotaviral activity of bovine milk components: Extending the list of inhibitory proteins and seeking a better understanding of their neutralization mechanism. Journal of Functional Foods 2018;44:103-11. [DOI: 10.1016/j.jff.2018.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Rodrigues CMC, Pinto MV, Sadarangani M, Plotkin SA. Whither vaccines? J Infect 2017;74 Suppl 1:S2-9. [PMID: 28646957 DOI: 10.1016/S0163-4453(17)30184-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
11 Arnold MM. Rotavirus Vaccines: Why Continued Investment in Research Is Necessary. Curr Clin Micro Rpt 2018;5:73-81. [DOI: 10.1007/s40588-018-0079-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Rahajamanana VL, Raboba JL, Rakotozanany A, Razafindraibe NJ, Andriatahirintsoa EJPR, Razafindrakoto AC, Mioramalala SA, Razaiarimanga C, Weldegebriel GG, Burnett E, Mwenda JM, Seheri M, Mphahlele MJ, Robinson AL. Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar. Vaccine 2018;36:7198-204. [PMID: 28958809 DOI: 10.1016/j.vaccine.2017.08.091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Babji S, Arumugam R, Priyahemavathy R, Sriraman A, Sarvanabhavan A, Manickavasagam P, Simon A, Aggarwal I, Moses PD, Arora R, Kang G. Genotype distribution of Group A rotavirus from southern India, 2005-2016. Vaccine 2018;36:7816-9. [PMID: 28844408 DOI: 10.1016/j.vaccine.2017.08.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
14 Yin Y, Dang W, Zhou X, Xu L, Wang W, Cao W, Chen S, Su J, Cai X, Xiao S, Peppelenbosch MP, Pan Q. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target. Virulence 2018;9:83-98. [PMID: 28475412 DOI: 10.1080/21505594.2017.1326443] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
15 Parrón JA, Ripollés D, Pérez MD, Calvo M, Rasmussen JT, Sánchez L. Antirotaviral Activity of Bovine and Ovine Dairy Byproducts. J Agric Food Chem 2017;65:4280-8. [PMID: 28489400 DOI: 10.1021/acs.jafc.7b01059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
16 Kawahara T, Makizaki Y, Oikawa Y, Tanaka Y, Maeda A, Shimakawa M, Komoto S, Moriguchi K, Ohno H, Taniguchi K. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One 2017;12:e0173979. [PMID: 28346473 DOI: 10.1371/journal.pone.0173979] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
17 Miura H, Kawamura Y, Sugata K, Koshiyama N, Yoshikawa A, Komoto S, Taniguchi K, Ihira M, Yoshikawa T. Rotavirus vaccine strain transmission by vaccinated infants in the foster home: Rotavirus Vaccination in the Foster Home. J Med Virol 2017;89:79-84. [DOI: 10.1002/jmv.24613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
18 Gómez D, Muñoz N, Guerrero R, Acosta O, Guerrero CA. PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal Villi. PPAR Res 2016;2016:4049373. [PMID: 27382365 DOI: 10.1155/2016/4049373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Colgate ER, Haque R, Dickson DM, Carmolli MP, Mychaleckyj JC, Nayak U, Qadri F, Alam M, Walsh MC, Diehl SA, Zaman K, Petri WA, Kirkpatrick BD. Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial. Clin Infect Dis 2016;63:634-41. [PMID: 27217217 DOI: 10.1093/cid/ciw346] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
20 Ramani S, Hu L, Venkataram Prasad BV, Estes MK. Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol 2016;2:263-73. [PMID: 28090561 DOI: 10.1016/j.jcmgh.2016.03.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
21 Do LP, Doan YH, Nakagomi T, Kaneko M, Gauchan P, Ngo CT, Nguyen MB, Yamashiro T, Dang AD, Nakagomi O. Molecular characterisation of wild-type G1P[8] and G3P[8] rotaviruses isolated in Vietnam 2008 during a vaccine trial. Arch Virol 2016;161:833-50. [PMID: 26711453 DOI: 10.1007/s00705-015-2706-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Pêra FF, Mutepfa DL, Khan AM, Els JH, Mbewana S, van Dijk AA, Rybicki EP, Hitzeroth II. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana. Virol J 2015;12:205. [PMID: 26626122 DOI: 10.1186/s12985-015-0436-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
23 Maffey L, Vega CG, Parreño V, Garaicoechea L. Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? Rev Argent Microbiol 2015;47:368-79. [PMID: 26654700 DOI: 10.1016/j.ram.2015.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
24 Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Donowitz M, Estes MK. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol 2016;90:43-56. [PMID: 26446608 DOI: 10.1128/JVI.01930-15] [Cited by in Crossref: 190] [Cited by in F6Publishing: 202] [Article Influence: 27.1] [Reference Citation Analysis]
25 Lua LH, Fan Y, Chang C, Connors NK, Middelberg AP. Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle. Vaccine 2015;33:5937-44. [PMID: 26387437 DOI: 10.1016/j.vaccine.2015.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
26 John J, Sarkar R, Muliyil J, Bhandari N, Bhan MK, Kang G. Rotavirus gastroenteritis in India, 2011-2013: revised estimates of disease burden and potential impact of vaccines. Vaccine 2014;32 Suppl 1:A5-9. [PMID: 25091681 DOI: 10.1016/j.vaccine.2014.03.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
27 Babji S, Arumugam R, Sarvanabhavan A, Moses PD, Simon A, Aggarwal I, Mathew A, Sr Anita, Kang G. Multi-center surveillance of rotavirus diarrhea in hospitalized children <5 years of age in India, 2009-2012. Vaccine 2014;32 Suppl 1:A10-2. [PMID: 25091661 DOI: 10.1016/j.vaccine.2014.03.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
28 Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol 2015;8:1-17. [PMID: 25465100 DOI: 10.1038/mi.2014.114] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
29 Noguera T, Wotring R, Melville CR, Hargraves K, Kumm J, Morton JM. Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic. World J Gastroenterol 2014; 20(34): 12301-12307 [PMID: 25232265 DOI: 10.3748/wjg.v20.i34.12301] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
30 Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. MyD88-mediated TLR signaling protects against acute rotavirus infection while inflammasome cytokines direct Ab response. Innate Immun 2015;21:416-28. [PMID: 25213347 DOI: 10.1177/1753425914547435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
31 Martinez M, Galeano ME, Akopov A, Palacios R, Russomando G, Kirkness EF, Parra GI. Whole-genome analyses reveals the animal origin of a rotavirus G4P[6] detected in a child with severe diarrhea. Infect Genet Evol 2014;27:156-62. [PMID: 25075468 DOI: 10.1016/j.meegid.2014.07.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
32 Arnoldi F, De Lorenzo G, Mano M, Schraner EM, Wild P, Eichwald C, Burrone OR. Rotavirus increases levels of lipidated LC3 supporting accumulation of infectious progeny virus without inducing autophagosome formation. PLoS One 2014;9:e95197. [PMID: 24736649 DOI: 10.1371/journal.pone.0095197] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
33 Li M, Monaco MH, Wang M, Comstock SS, Kuhlenschmidt TB, Fahey GC Jr, Miller MJ, Kuhlenschmidt MS, Donovan SM. Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota. ISME J 2014;8:1609-20. [PMID: 24522264 DOI: 10.1038/ismej.2014.10] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
34 Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis 2014;210:171-82. [PMID: 24436449 DOI: 10.1093/infdis/jiu037] [Cited by in Crossref: 128] [Cited by in F6Publishing: 126] [Article Influence: 16.0] [Reference Citation Analysis]
35 Sen A, Rott L, Phan N, Mukherjee G, Greenberg HB. Rotavirus NSP1 protein inhibits interferon-mediated STAT1 activation. J Virol 2014;88:41-53. [PMID: 24131713 DOI: 10.1128/JVI.01501-13] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
36 Kang G. New-Generation Treatment? Targeted Antiviral Therapy for Rotavirus. Gastroenterology 2013;145:711-4. [DOI: 10.1053/j.gastro.2013.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Newell EW, Sigal N, Nair N, Kidd BA, Greenberg HB, Davis MM. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol 2013;31:623-9. [PMID: 23748502 DOI: 10.1038/nbt.2593] [Cited by in Crossref: 200] [Cited by in F6Publishing: 183] [Article Influence: 22.2] [Reference Citation Analysis]
38 Vega CG, Bok M, Vlasova AN, Chattha KS, Gómez-Sebastián S, Nuñez C, Alvarado C, Lasa R, Escribano JM, Garaicoechea LL, Fernandez F, Bok K, Wigdorovitz A, Saif LJ, Parreño V. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog 2013;9:e1003334. [PMID: 23658521 DOI: 10.1371/journal.ppat.1003334] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
39 Rose J, Parashar UD. Should India launch a national immunisation programme against rotavirus? Yes. BMJ 2012;345:e7818. [PMID: 23203999 DOI: 10.1136/bmj.e7818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Current Opinion in Virology 2012;2:434-42. [DOI: 10.1016/j.coviro.2012.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]